Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data

View ORCID ProfileThomas J.S. Durant, Christopher D. Koch, Christopher A. Kerantzas, David R. Peaper
doi: https://doi.org/10.1101/2021.04.26.21254638
Thomas J.S. Durant
1Yale University School of Medicine, Department of Laboratory Medicine: 55 Park Street PS345D, New Haven, CT 06511
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas J.S. Durant
Christopher D. Koch
1Yale University School of Medicine, Department of Laboratory Medicine: 55 Park Street PS345D, New Haven, CT 06511
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Kerantzas
1Yale University School of Medicine, Department of Laboratory Medicine: 55 Park Street PS345D, New Haven, CT 06511
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Peaper
1Yale University School of Medicine, Department of Laboratory Medicine: 55 Park Street PS345D, New Haven, CT 06511
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.peaper{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.04.26.21254638
History 
  • April 27, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Thomas J.S. Durant, MD1,
  2. Christopher D. Koch, PhD1,
  3. Christopher A. Kerantzas, MD, PhD1 and
  4. David R. Peaper, MD, PhD1,*
  1. 1Yale University School of Medicine, Department of Laboratory Medicine: 55 Park Street PS345D, New Haven, CT 06511
  1. ↵* To whom correspondence should be addressed: Department of Laboratory Medicine, 55 Park Street PS345D, New Haven, CT 06511., E-mail: david.peaper{at}yale.edu
Back to top
PreviousNext
Posted April 27, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data
Thomas J.S. Durant, Christopher D. Koch, Christopher A. Kerantzas, David R. Peaper
medRxiv 2021.04.26.21254638; doi: https://doi.org/10.1101/2021.04.26.21254638
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data
Thomas J.S. Durant, Christopher D. Koch, Christopher A. Kerantzas, David R. Peaper
medRxiv 2021.04.26.21254638; doi: https://doi.org/10.1101/2021.04.26.21254638

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)